Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$49.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AbbVie Inc Raises FY 2013 EPS Guidance


Friday, 26 Jul 2013 07:53am EDT 

AbbVie Inc announced that it is raising its diluted earnings-per-share guidance for fiscal 2013 to $3.07 to $3.13 (from $3.03 to $3.13) on an adjusted basis, or $2.66 to $2.72 on a GAAP basis. The Company's 2013 adjusted diluted earnings-per-share guidance excludes $0.41 per share of intangible asset amortization expense, acquired in-process research and development, and other specified items primarily associated with certain separation-related costs and ongoing restructuring activities. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $3.12 for fiscal 2013. 

Company Quote

67.92
1.35 +2.03%
18 Dec 2014